Fibromyalgia Trial, Recruiting NCT07245303 Sponsor: University of North Carolina, Chapel Hill Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07245303
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older.
  • You must not be planning any changes to your medications or treatments in the next 3 months.
  • You must be willing and able to have an MRI scan.
  • You must not feel afraid of enclosed spaces (claustrophobia).
  • You must be alert, aware of your surroundings, and able to give your consent to take part.
  • You must be able to speak and read English.

For people with chronic widespread pain/fibromyalgia only:

  • You must score at a certain level on standard fibromyalgia questionnaires that measure how widespread your pain is and how severely it affects you (confirm with trial site).
  • Your pain must have been present for at least 3 months.
  • Your pain must affect at least 4 out of 5 areas of the body.
  • Your average pain level over the past month must be at least 4 out of 10.

For people with a specific eye condition called Congenital Stationary Night Blindness only:

  • 2 participants who have been diagnosed with this inherited night vision condition and do not have chronic widespread pain are also being recruited.

Who may not be able to join:

  • You have a condition that affects your retina or causes vision impairment.
  • You experience sensitivity to light or discomfort around light (for example, as seen in some autoimmune conditions like lupus).
  • You have uveitis, cataracts, colour blindness, or a history of seizures.
  • You are planning any changes to pain treatments in the next 3 months, such as surgery, new medications, injections, or other pain procedures.
  • You are currently imprisoned.
  • You are pregnant.
  • You have anything in or on your body that makes an MRI unsafe, such as certain metal implants or medical devices that are not MRI-compatible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew Mauck, MD, PhD, University of North Carolina, Chapel Hill

Phone: 919-966-5136

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 February 2026
Est. completion
31 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Resting State Functional Connectivity-seed Voxel Analysis in Participants with cMSP and Healthy Controls; Whole Brain Evoked Activation Patterns in Response to Chromatic Stimuli Contrasted with Achromatic Stimuli in Participants with cMSP and Healthy Controls; Whole Brain Evoked Activation Patterns in Response to Chromatic Stimuli Contrasted with Achromatic Stimuli in Patients with cMSP and Healthy Controls Exposed to a Pressure Pain Stimulus

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov